MAPK7 and cholangiocarcinoma: In this study, it was showed that the treatment of miR-200b could target AP-2α/MAPK7 in CCA xenografts models in order to interfere the regulatory loop involving miR-200b and TGF-β to repress EMT for cancer metastasis.